baber/WOPTO huggingface dataset:
Patent JP-2844004-B2 (JP)
IPC: C08G59/40
Filed: 1990-01-12
Granted: 1999-01-06
Abstract: New polyoxazolidines can be defined by means of the general formula:   <CHEM> wherein R, R1, R2, R3, R4, R5, R6 and n have the meaning as reported in the specification. These polyoxazolidines are useful as crosslinking agents for moisture-hardening systems on the basis of polyisocyanates, acrylate polymers and polyepoxides, in compositions for coatings, sealant compositions and adhesive compositions.
Patent JP-H0419867-B2 (JP)
IPC: A24D1/22
Filed: 1990-01-18
Abstract: A member is provided for conducting heat from a combustible fuel element to an 'aerosol' generator which includes aerosol-forming material. The conducting member is spaced from the lighting end of the fuel element by at least 5 mm., and can circumscribe both the fuel element and generator, at least partially. Alternatively, the conductor contacts the fuel element along less than approx. half its length, e.g. it is embedded within it. Pref. the fuel element has a length of less than approx. 30 mm and has a density of about 0.5 g/cc.
Patent AU-769989-B2 (AU)
Title: Bicyclic nitrogen heterocycles
Inventor: HARRIS WILLIAM
IPC: A61P9/00
Filed: 1999-10-13
Granted: 2004-02-12
Abstract: Amino-substituted dihydropyrimido[4,5-d]pyrimidinones of the formula in which R1 represents hydrogen, lower alkyl, aryl, aryl-lower alkyl, heteroaryl, heteroaryl-lower alkyl, lower cycloalkyl or lower cycloalkyl-lower alkyl, R2 represents lower alkyl, aryl, aryl-lower alkyl, heteroaryl, heteroaryl-lower alkyl, lower cycloalkyl or lower cycloalkyl-lower alkyl, and R3 represents hydrogen, lower alkyl, aryl, aryl-lower alkyl, heteroaryl, heteroaryl-lower alkyl, lower cycloalkyl, lower cycloalkenyl or lower cycloalkyl-lower alkyl, and pharmaceutically acceptable salts thereof are protein kinase inhibitors. They can be used in the treatment or prophylaxis of inflammatory, immunological, oncological, bronchopulmonary, dermatological and cardiovascular disorders, in the treatment of asthma, central nervous system disorders or diabetic complications or for the prevention of graft rejection following transplant surgery.
Patent AU-656943-B2 (AU)
Title: Treatment of gases
Inventor: WATSON RICHARD WILLIAM
IPC: B01D53/75
Filed: 1992-02-13
Granted: 1995-02-23
Abstract: A gas stream comprising hydrogen sulphide is preheated in a heat exchanger 2. Part of its hydrogen sulphide content is burnt in a furnace 6 to form sulphur dioxide and water vapour. Pure oxygen or oxygen-enriched air is used to support combustion. The sulphur dioxide reacts with residual hydrogen sulphide to form sulphur vapour and further water vapour. The sulphur vapour is removed from the gas stream in a condenser 14. The gas stream is then divided into first and second subsidiary streams. The hydrogen sulphide content of the first subsidiary stream is totally converted to sulphur dioxide in an incinerator 16 using pure oxygen or oxygen-enriched air to support its combustion. Water vapour is then removed from the first subsidiary stream in a condenser 20, and the resulting gas stream now relatively rich in sulphur dioxide, is recycled to the furnace 6. The second subsidiary stream is subjected to a plurality of stages 26 of catalytic reaction between hydrogen sulphide and sulphur dioxide to form further sulphur vapour which is removed therefrom. <IMAGE>
Patent AU-595420-B2 (AU)
Title: Power supply
Inventor: LAIDLER GRAHAM ANTHONY
IPC: H02M3/337
Filed: 1988-02-02
Granted: 1990-03-29
Abstract: A power supply receives and rectifies mains voltage using bridge D1-D4. This is used by a pair of transistors Q1 and Q2 to alternate the supply to a transformer T via capacitor C8. Outputs are available from secondary windings T2, T6 and T7. Further windings T4 and T5 provide an internal power source for system circuitry which includes optical regulation via IC1 and optical switching control using IC2.
Patent AU-605280-B2 (AU)
Title: Use of 2,6 dinitro-aniline derivatives in hair tinting agents and new derivatives of 2,6 dinitro-aniline
Inventor: CLAUSEN THOMAS
IPC: A61Q5/06
Filed: 1988-03-29
Granted: 1991-01-10
Abstract: PCT No. PCT/EP88/00260 Sec. 371 Date Nov. 21, 1989 Sec. 102(e) Date Nov. 21, 1989 PCT Filed Mar. 29, 1988 PCT Pub. No. WO88/08696 PCT Pub. Date Nov. 17, 1988.The method of dyeing hair comprises applying to the hair a dye containing a 2,6-dinitro-aniline derivative having the general formula (I)   <IMAGE> (I)  wherein R represents H, C1-C4 alkyl, C2-C4 monohydroxy alkyl or C3-C4-dihydroxy alkyl and X represents one of the radicals C1-C4 alkyl, C2-C4 monohydroxy alkyl, C1-C4 perfluoro alkyl, C1-C4 alkoxy, C2-C4 monohydroxy alkoxy, C3-C4 dihydroxy alkoxy or halogen. The present invention also comprises hair dyes containing at least one compound having the formula (I) and novel 2,6-dinitro-aniline derivatives. The dyes having the formula (I) have good physiological properties and provide all the yellow shades required for dyeing from a bluish-tinged lemon-yellow via a pure yellow to red-orange.
Patent AU-626127-B2 (AU)
Title: Improved sucrose fatty acid ester compositions and shortenings and margarines made therefrom
Inventor: ORPHANOS PETER DEAN
IPC: A23D7/02
Filed: 1988-05-05
Granted: 1992-07-23
Abstract: The present invention relates to intermediate melting sucrose fatty acid ester compositions that are capable of rapid crystallization from a melted state. The compositions comprise 60% to 97% by weight intermediate melting sucrose fatty acid esters and 3% to 40% hardstock triglycerides or hardstock polyol fatty acid esters. Preferably the average fatty acid chain length of the hardstock material fatty acids is not less than the average fatty acid chain length of the intermediate melting sucrose ester fatty acids. The sucrose fatty acid esters are characterized by their rheology, liquid/solid stability, iodine value, and solids at body temperature. Rapid crystallization of the esters is useful in preventing anal leakage, and it could also translate into a reduction of post-hardening in shortenings and margarines, and into improved high temperature stability and temperature cycling stability as may be encountered during distribution of these products to the end user.
Patent AU-646735-B2 (AU)
Title: Absorbent wound filler
Inventor: CILENTO RODOLFO D
IPC: A61L15/24
Filed: 1992-05-08
Granted: 1994-03-03
Abstract: An absorbent wound filler having high capacity for absorbing wound exudate comprising a polymeric matrix having absorbing powders dispensed within the matrix and method of treating an exudating wound by applying the wound filler to the wound. The absorbing powders contain sodium calcium alginates and also may contain cross-linked sodium carboxymethylcellulose, absorbent polyacrylates and water soluble hydrocolloids.
Patent AU-603231-B2 (AU)
Title: Ceric oxide with a large specific surface at high temperatures and method of manufacture
Inventor: LOARER JEAN-LUC LE
IPC: C01F17/235
Filed: 1988-06-29
Granted: 1990-11-08
Abstract: A process for obtaining a ceric oxide of large specific surface. 
<??>The process is characterised in that a ceric hydroxide prepared by hydrolysis of a solution of a cerium (IV) salt is subjected to a solvothermal treatment before the calcination operation. 
<??>The ceric oxide obtained has a large specific surface at high temperature.
Patent AU-669108-B2 (AU)
Title: Washing and/or conditioning composition for keratinous materials based on a silicone containing a hydroxyacylamino functional group and on substantive polymers
Inventor: DUBIEF CLAUDE
IPC: A61K8/92
Filed: 1992-07-03
Granted: 1996-05-30
Abstract: The invention relates to a composition for washing and/or conditioning keratinous materials, containing in an aqueous medium appropriate for these materials at least one silicone containing a hydroxyacylamino functional group, at least one substantive polymer and at least one detergent surface-active agent.
Patent AU-780805-B2 (AU)
Title: Soluble receptor BR43x2 and methods of using
Inventor: GROSS JANE A
IPC: A61P11/00
Filed: 2000-01-07
Granted: 2005-04-21
Abstract: There is provided a fusion protein consisting of a first portion and a second portion joined by a peptide bond, wherein said first portion consists of an amino acid sequence selected from: (i) amino acid residues 25-104 of SEQ ID NO: 6; (ii) amino acid residues 34-66 of SEQ ID NO: 6; (iii) amino acid residues 71-104 of SEQ ID NO: 6; and (iv) amino acid residues 34-66 and 71-104 of SEQ ID NO: 6; and said second portion is an immunoglobulin heavy chain constant region. There is also provided an antibody or antibody fragment that specifically binds to a polypeptide selected from SEQ ID NO: 59 or SEQ ID N: 60. There is also provided an antibody or antibody fragment that specifically binds to a ztnf4 polypeptide, for use in treating systemic lupus erythematosus in a mammal.
Patent AU-680373-B2 (AU)
Title: Oligomers of cyclopentadiene and process for making them
Inventor: BOULTON JAMES ROBERTS
IPC: C08F136/04
Filed: 1995-06-07
Granted: 1997-07-24
Abstract: The invention provides a two-step process for converting cyclopentadiene dimer to a high density fuel mixture comprising the steps of: (a) reacting said cyclopentadiene dimer in the presence of a solid catalyst comprising a porous crystalline material having a Constraint Index of from about 0.1 to about 12 under oligomerization/isomerization conditions to convert at least a portion of said cyclopentadiene dimer to a normally liquid intermediate product containing cyclopentadiene trimer, cyclopentadiene tetramer, and the isomerized and oligomerized products derived from the reaction of at least three cyclopentadiene monomer units; (b) hydrogenating said normally liquid intermediate product of step (a) in the presence of a hydrogenation catalyst to form a normally liquid high energy density fuel.
Patent AU-774559-B2 (AU)
Title: Torquable guiding member system
Inventor: JACOBSEN STEPHEN C
IPC: A61M25/00
Filed: 2000-12-22
Granted: 2004-07-01
Abstract: A catheter guidewire includes an elongate solid body about which a catheter may be threaded for guidance to a target location in a vasculature passageway of a body. The elongate body includes a proximal end and a distal end, with the distal end being curved. Cuts are formed either by saw-cutting, laser cutting or etching at spaced-apart locations along the length of the body to increase its lateral flexibility. Integral beams are also formed within the body to maintain its torsional strength. The relative location and size of cuts and beams may be selectively adjusted so as to control the direction and degree of flexure, and the change in torsional stiffness relative to flexibility.
Patent AU-566355-B2 (AU)
Title: Aluminium electrolytic reduction cell linings
Inventor: DEWING ERNEST WILLIAM
IPC: C25C3/08
Filed: 1984-06-12
Granted: 1987-10-15
Abstract: The invention concerns cells for production of Al by electrolysis of an alumina-containing electrolyte based on cryolite and having a lining based on alumina for containing the electrolyte. A layer containing an alkali or alkaline earth metal compound, e.g. sodium aluminate, is included in the lining, preferably around the 880 DEG C. isotherm when the cell is in operation. On penetration of the lining by the electrolyte, the compound dissolves in or reacts with the electrolyte so as to raise the solidus and reduce or prevent further penetration.
Patent AU-662788-B2 (AU)
Title: Preparation of alpha, beta-unsaturated enones
Inventor: HERRINTON PAUL MATTHEW
IPC: C07C49/603
Filed: 1992-12-02
Granted: 1995-09-14
Abstract: A process for oxidizing silyl enone ethers to alpha, beta-unsaturated enodes having the formulas    <IMAGE>  I   <IMAGE>  II  which comprises reacting the appropriate silyl enone ether with a radical generated by the metal catalyst decomposition of a peroxide composition.
Patent AU-690327-B2 (AU)
Title: Injectable polyethylene oxide gel implant and method for production
Inventor: VILLAIN FRANCK L
IPC: C08J3/075
Filed: 1995-08-30
Granted: 1998-04-23
Abstract: A biocompatible polyethylene oxide gel implant and method for production which can be injected into the human body for tissue replacement and augmentation. The implant is prepared by dissolving a sample of essentially pure polyethylene oxide in a saline solution in a sealed canister, removing all free oxygen from the container and replacing it with an inert gas, such as argon, and irradiating the canister with a gamma ray source to simultaneously crosslink the polyethylene oxide while sterilizing it. The gel can then be placed into a syringe and injected into the body.
Patent AU-708142-B2 (AU)
Title: Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
Inventor: LEONG SIMON
IPC: F21V9/16
Filed: 1995-09-22
Granted: 1999-07-29
Abstract: Multiple sclerosis and rheumatoid arthritis can be treated effectively using photodynamic therapy. In this protocol, a photoactive compound is administered, allowed to distribute in the effected subject, and the subject is then irradiated to activate the photoactive compound. Alternatively, the blood of a subject to be treated can be subjected to PDT extracorporeally. In the case of rheumatoid arthritis, localized treatment at the joints may also be employed.
Patent AU-763191-B2 (AU)
Title: Improvements in or relating to diagnostic/therapeutic agents
Inventor: CUTHBERTSON ALAN
IPC: A61K41/00
Filed: 1999-04-22
Granted: 2003-07-17
Abstract: Novel membrane-forming amphiphilic lipopeptides comprising one or more peptide moieties containing 2-50 aminoacyl residues and one or more hydrocarbon chains containing 5-50 carbon atoms. Such lipopeptides may be used in the formation of stabilised gas microbubble dispersions suitable for use as diagnostic and/or therapeutic agents, for example as ultrasound contrast agents.
Patent AU-612268-B2 (AU)
Title: Compound steel work pieces and method for their production
Inventor: KROISENBRUNNER WALTER
IPC: B29C48/09
Filed: 1989-06-20
Granted: 1991-07-04
Abstract: The invention relates to a composite steel workpiece and a method of manufacturing same, in which a supporting sleeve is provided with at least one clearance, which clearance is provided with a wear-resistant and/or corrosion-resistant lining, which is bonded to the supporting sleeve to form a metal composite. The invention provides that, in particular for forming a twin-screw or multiple- screw barrel for plastics processing, the supporting sleeve, provided with at least one core at the point(s) of the desired clearance(s), is subjected together with the core(s) to a hot forming process at an appropriate temperature, in particular a cross-sectional reduction, the core(s) is (are) given a non-circular cross-sectional shape and the clearance(s) is (are) formed in the core(s).
Patent AU-612502-B2 (AU)
Title: Polyolefin films having improved barrier properties
Inventor: YEH GENE H
IPC: C08L23/02
Filed: 1989-07-10
Granted: 1991-07-11
Abstract: The barrier properties of crystalline polyolefin film can be improved substantially by incorporating a precise amount of a partially incompatible wax into the polyolefin. When the polyolefin is polypropylene or polybutylene, the wax is preferably a paraffin wax. The precise amount of wax, which produces optimum improvement in barrier properties, lies in the range of about 3 to 10 percent based on the weight of the polyolefin. The range in which excellent results are obtained can be broadened by contacting the film with a cooling medium immediately after it is extruded. The film may be annealed to further improve the barrier properties.
Patent AU-610739-B2 (AU)
Title: Thiazolo (5,4-b)azepine compounds
Inventor: AONO TETSUYA
IPC: A61P29/00
Filed: 1989-07-21
Granted: 1991-05-23
Abstract: New thiazolo [5,4-b]azepine compounds represented by <CHEM> ,wherein R<1> is a hydrogen atom, an aliphatic group which may be substituted, a carboxylic acyl group which may be substituted or a sulfonic acyl group which may be substituted; R<2> is a hydrogen atom, an aromatic group which may be substituted or an aliphatic group which may be substituted, which are capable of e.g., inhibiting lipoperoxide formation.
Patent AU-695739-B2 (AU)
Title: Injection-molded dosage form
Inventor: DONG LIANG C
IPC: A61K47/34
Filed: 1995-10-20
Granted: 1998-08-20
Abstract: The invention relates to a membrane, which can be injection moulded, comprising polycaprolactone and at least one of a poly (alkylene oxide), poly (ethylene glycol) or poly (hydroxypropylcellulose).
Patent AU-615104-B2 (AU)
Title: The use of asymmetric membranes in delivery devices
Inventor: THOMBRE AVINASH GOVIND
IPC: A61K9/22
Filed: 1989-08-29
Granted: 1991-09-19
Abstract: A device for controlled release of an active substance through one or more asymmetric membranes by diffusion and/or osmotic pumping.
Patent AU-723045-B2 (AU)
Title: Transmitting and receiving method and radio system
Inventor: HAKKINEN HANNU
IPC: H04W72/04
Filed: 1997-09-05
Granted: 2000-08-17
Abstract: The invention relates to a transmitting and receiving method and a radio system. In a transmitter the signals to be transmitted are spread coded in means and modulated by subcarriers in means. In a receiver (R) the signals are demodulated in means and submitted to multiuser detection in means by using the subcarriers to limit the number of detectable signals in the means. The receiver uses multiuser detection for reducing multiple access interference and correcting frequency-selective fading.
Patent AU-640124-B2 (AU)
Title: Butter containing spread and process for preparation thereof
IPC: A23D7/00
Filed: 1990-02-27
Granted: 1993-08-19
Abstract: The present invention relates to a butter-containing spread, and a process for the production of the said spread. The present invention provides an edible emulsion comprising 30-70%wt of an aqueous phase CHARACTERISED IN THAT it comprises both wet-concentrated and dry butterfat in a weight ratio of 1:10 to 10:1. It is believed that one advantage of using both wet and dry butterfat components stems from the difference in the organoleptic properties of these two components. The term wet-concentrated butterfat is intended to embrace within its scope both concentrated cream, having a fat content in excess of 40%wt and butter. Dry-butterfat is intended to embrace butter-fats which have been rendered anhydrous at some time during the concentration process. The dry butterfat component contributes a different set of flavour components to the product. It is believed that rendering the butterfat anhydrous causes the formation of flavour components which are not present in fresh dairy butter or cream.
Patent AU-638982-B2 (AU)
Title: Use of cytokines
IPC: A61P35/00
Filed: 1990-04-10
Granted: 1993-07-15
Abstract: The invention relates to the use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions. The pharmaceutical composition according to the invention may contain interferon, tumor necrosis factor, or a combination of both interferon and tumor necrosis factor.
Patent AU-636885-B2 (AU)
Title: Cutting head with oxygen jet
IPC: B23K7/10
Filed: 1990-05-08
Granted: 1993-05-13
Abstract: A cutting head constituted by a cutting nozzle (2) with a cutting oxygen conduit (6) and with radial ribs (11) at the outer periphery, the whole being force-fitted in a skirt (3) thus forming conduits for a oxy-combustible mixture (37), each delimited by two adjacent ribs. 
<??>Such a nozzle which permits better thermal dissipation can be produced with reduced dimensions. 
<IMAGE>
Patent AU-538116-B2 (AU)
Title: Lead additive
Inventor: LIMARE ARMAND
IPC: C03C1/02
Filed: 1980-03-05
Granted: 1984-08-02
Abstract: A lead additive containing a lead oxide and an alkaline silicate which is resistant to dusting, abrasion and segregation. The weight ratio of lead to alkaline silicate, calculated as PbO and SiO2, respectively, is greater than about 95:5; the moisture content is less than or equal to about 2%; and the density is less than about 5 g/cm3. The process for producing these additives involve forming a paste of the lead oxide and alkaline silicate, conditioning the paste to form granules and heat treating the granules.
Patent AU-756872-B2 (AU)
Title: Water fuel emulsified compositions
Inventor: DALY DANIEL T
IPC: C10L1/32
Filed: 1999-09-07
Granted: 2003-01-23
Abstract: This invention relates to an emulsified water-blended fuel composition comprising: (A) a hydrocarbon boiling in the gasoline or diesel range; (B) water; (C) a minor emulsifying amount of at least one fuel-soluble salt made by reacting (C)(I) at least one acylating agent having about 16 to 500 carbon atoms with (C)(II) ammonia and/or at least one amine; and (D) about 0.001 to about 15% by weight of the water-blended fuel composition of a water soluble, ashless, halogen-, boron-, and phosphorus-free, amine salt, distinct from component (C). In one embodiment, the composition further comprises (E) at least one cosurfactant distinct from component (C); in one embodiment, (F) at least one organic cetane improver; and in one embodiment, (G) at least one antifreeze. The invention also relates to a method for fueling an internal combustion engine comprising fueling said engine with the composition of the present invention.
Patent AU-757178-B2 (AU)
Title: Method for utilizing local resources in a communication system
Inventor: LINDEN MIKAEL
IPC: H04W80/12
Filed: 1999-09-20
Granted: 2003-02-06
Abstract: The invention relates to a method in data transmission between a first mobile station (MS, MS1, MS2), a second mobile station (MS, MS1, MS2), and advantageously also a server (3, SERVER), wherein the first mobile station (MS, MS1, MS2) and the second mobile station (MS, MS1, MS2) comprise protocol means (100-106) for generating and directing a request (REQUEST) which contains at least address information (URI, URL, URN) for identifying the destination of the request (REQUEST), and wherein at least the first mobile station (MS, MS1, MS2) comprises a first local resource (SC, 4), such as a smart card, connected to the same. In the information, the address information (URI, URL, URN) of the request (REQUEST) is established to identify said first local resource (SC, 4), and the request (REQUEST) is generated and directed at least partly with the help of said protocol means (100-106).
Patent AU-590295-B2 (AU)
Title: Derivatives of halogeno biphenyl primary alcohols useful in therapeutics for the treatment of atherosclerosis
Inventor: COUSSE HENRI
IPC: C07C43/174
Filed: 1986-07-07
Granted: 1989-11-02
Abstract: The invention relates to new derivatives of biphenyl primary alcohols, their preparation and use as medicaments useful in the treatment and prevention of atherosclerotic disorders. The new derivatives have the general formula   <IMAGE>   in which X represents a halogen atom, and more particularly chlorine, bromine or fluorine in ortho or meta position, R represents an alkyl, amino alkyl, pyridyl alkyl or acyl radical and more particularly   <IMAGE> +TR  <IMAGE>   and acetyl.
Patent AU-680874-B2 (AU)
Title: Inhalation device
Inventor: CHAWLA BRINDRA PAUL SINGH
IPC: A61M13/00
Filed: 1994-02-28
Granted: 1997-08-14
Abstract: A device for the administration of powdered inhalation medicament contained initially in a capsule having at least one aperture formed therein, comprising a swirl chamber (1) adapted to receive the medicament capsule; a mouthpiece (2) communicating with the swirl chamber (1) and separated therefrom by a grid (4); at least one air inlet (5) in tangential communication with the swirl chamber (1) whereby air can be drawn through the device via the mouthpiece (2) to cause a swirling air flow through the swirl chamber (1); and a cover member (7), having a continuous substantially planar inner surface, provided on the base of the swirl chamber (1) remote from the mouthpiece (2); said cover (7) being moveable between a first position in which the capsule can be inserted into the swirl chamber (1) and a second position in which the capsule is retained in the swirl chamber (1) and rotates upon air being drawn through the device, thereby dispensing the medicament contained therein.